SUGAR LAND--December 10, 2008--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--As 2008 winds to a close, the Pharmaceutical-Biotech Industry will have completed construction on a total of 76 new plants and research centers across North America. A recent survey of active reported projects in Industrial Info's Pharmaceutical Tracker - Online Database reveals that cumulatively, the projects represent a potential total investment value of $4 billion, which includes both original construction costs and possible future phases that are already planned or under consideration.

Companies featured: Cytogenix (NASDAQ:CYGX)

Companies featured in this segment: Alcoa (NYSE:AA), AK Steel (NYSE:AKS), U.S. Steel (NYSE:X), Freeport-McMoRan (NYSE:FCX), ThyssenKrupp (FRA:TKA), Holcim (VTX:HOLN), Canadian Natural Resources Limited (NYSE:CNQ), Cytogenix (NASDAQ:CYGX), Dow Chemical Company (NYSE:DOW), 3M (NYSE:MMM), Sony Corporation (NYSE:SNE), Cameco Corporation (NYSE:CCJ), KBR Incorporated (NYSE:KBR), Global Investment House (KUW:GLOBAL), Jordan Phosphate Mines Company (AFM:JOPH), Arab Potash Company (AFM:APOT), Southern Company (NYSE:SO), McDermott International Incorporated (NYSE:MDR), and Toshiba Corporation (OTC:TOSBF).